Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03126916
Brief Title: Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma

First Submitted : April 17, 2017
First Submitted that Met QC Criteria : April 24, 2017
First Posted : April 25, 2017

Last Update Submitted that Met QC Criteria : February 3, 2021
Last Update Posted : February 4, 2021